WILMINGTON, N.C., March 21 /PRNewswire-FirstCall/ --
aaiPharma Inc. (Nasdaq: AAII) announced today that Dr. Philip Tabbiner,
President and Chief Executive Officer of aaiPharma, will be presenting at the
Banc of America Securities 2003 Healthcare Conference on Wednesday, March 26,
at 8:00 AM Pacific Standard Time (11:00 AM EST). The conference is being held
in Las Vegas, Nevada.
The presentation will be webcast live over the Internet, then archived and
available for 10 days following the event. The web cast will be accessible
through the Company's website at http://www.aaipharma.com.
About aaiPharma
aaiPharma Inc. is a leading, science-based specialty pharmaceutical
company with corporate headquarters in Wilmington, North Carolina. With more
than 23 years of drug development expertise and a proven sales and marketing
track record, the Company is focused on acquiring, improving and marketing
well-known, branded medicines in pain management, gastroenterology and
critical care. In addition to its branded product portfolio and robust
pipeline, aaiPharma continues to offer comprehensive drug development services
to the pharmaceutical, biotechnology, generic and device industries through
its services division, AAI International. For more information, please visit
aaiPharma's website at http://www.aaipharma.com.
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
media, Andrea L. Johnston Vice President,
Corporate Communications, 910-254-7340, or investors, James B.
Sloan, Jr., Senior Vice President, Corporate Finance,
+1-910-254-7690, both of aaiPharma Inc.
|
